White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort Study

White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort Study

Introduction: Whether white blood cell (WBC) counts are predictors for the effectiveness of thiopurine treatment in ulcerative colitis (UC) has been inconclusive in previous studies with small sample sizes. We investigated the association between WBC counts and future relapses in UC patients in a la...

Full description

Bibliographic Details
Main Authors: Hiroki Kiyohara, Hajime Yamazaki, Kei Moriya, Naohiko Akimoto, Shoichiro Kawai, Kento Takenaka, Tomohiro Fukuda, Keiichi Tominaga, Junji Umeno, Shinichiro Shinzaki, Yusuke Honzawa, Tomohisa Takagi, Hitoshi Ichikawa, Toshiyuki Endo, Ryo Ozaki, Akira Andoh, Katsuyoshi Matsuoka, Toshifumi Hibi, Taku Kobayashi
Format: Article
Language:English
Published: Karger Publishers 2023-12-01
Series:Inflammatory Intestinal Diseases
Subjects:
immunomodulator
inflammatory bowel disease
leukocyte
maintenance therapy
remission
ulcerative colitis
Online Access:https://beta.karger.com/Article/FullText/535889

Internet

https://beta.karger.com/Article/FullText/535889

Similar Items